CANOC Publications
August, 2013 - AIDS
Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large Canadian Observational Cohort
Ndumbi P, Gillis J, Raboud J, Klein M, Cooper C, Hogg RS, Loutfy MR, Machouf N, Burchell A, Montaner JS, Tsoukas C; The Canadian Observational Cohort (CANOC) collaboration.
Plain Language Summary PDFJune, 2013 - Stat Med
Armitage Lecture 2011: the design and analysis of life history studies
April, 2012 - J Infect Dis
Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis
Grennan JT, Loutfy MR, Su D, Harrigan PR, Cooper C, Klein M, Machouf N, Montaner JS, Rourke S, Tsoukas C, Hogg B, Raboud J; CANOC Collaboration.
Plain Language Summary PDFMarch, 2012 - HIV Clin Trials
Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapy
Raboud J, Anema A, Su D, Klein MB, Zakaryan A, Swan T, Palmer A, Hosein S, Loutfy MR, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Hogg RS, Cooper C; Canadian Observational Cohort (CANOC) Collaboration.
Plain Language Summary PDFSeptember, 2011 - J Acquir Immune Defic Syndr
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy
Tan DH, Chan K, Raboud J, Cooper C, Montaner JS, Walmsley S, Hogg RS, Klein MB, Machouf N, Rourke SB, Tsoukas C, Loutfy MR; CANOC Collaboration.
Plain Language Summary PDFJuly, 2011 - HIV Med
Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort
Cescon AM, Cooper C, Chan K, Palmer AK, Klein MB, Machouf N, Loutfy MR, Raboud J, Rachlis A, Ding E, Lima VD, Montaner JS, Rourke SB, Smieja M,Tsoukas C, Hogg RS; CANOC Collaboration.
Plain Language Summary PDFFebruary, 2011
Cohort profile: the Canadian Observational Cohort collaboration
Palmer AK, Klein MB, Raboud J, Cooper C, Hosein S, Loutfy M, Machouf N, Montaner J, Rourke SB, Smieja M, Tsoukas C, Yip B, Milan D, Hogg RS; CANOC Collaboration.
December, 2010 - J Acquir Immune Defic Syndr
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression
Loutfy MR, Genebat M, Moore D, Raboud J, Chan K, Antoniou T, Milan D, Shen A, Klein MB, Cooper C, Machouf N, Rourke SB, Rachlis A, Tsoukas C, Montaner JS, Walmsley SL, Smieja M, Bayoumi A, Mills E, Hogg RS; CANOC Collaboration.
Plain Language Summary PDFFebruary, 2010 - BMC Infect Dis
Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries
Raboud JM, Loutfy MR, Su D, Bayoumi AM, Klein MB, Cooper C, Machouf N, Rourke S, Walmsley S, Rachlis A, Harrigan PR, Smieja M, Tsoukas C, Montaner JS, Hogg RS; CANOC Collaboration.
Plain Language Summary PDF